Cannabis Sativa Monograph Pdf File

File
  1. Andersson, M. S. & M. C. de Vicente. 2010. Gene flow between crops and their wild relatives. Johns Hopkins University Press, Baltimore.Google Scholar
  2. Benet, S. 1975. Early diffusion and folk uses of hemp. Pp 39–49. In: V. Rubin (ed). Cannabis and culture. Mouton, The Hague.Google Scholar
  3. Bouquet, R. J. 1950. Cannabis. Bulletin on Narcotics 2(4): 14–30.Google Scholar
  4. Brickell, C. D., C. Alexander, J. C. David, W. L. A. Hetterscheid, A. C. Leslie, V. Malecot, X. Jin & J. J. Cubey. 2009. International code of nomenclature for cultivated plants. International Society for Horticultural Science, Leuven. http://www.actahort.org/chronica/pdf/sh_10.pdf (accessed Oct 16, 2015).
  5. Burstein, S. 2015. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry 23: 1377–1385.CrossRefGoogle Scholar
  6. Carlini, E. A. & J. M. Cunha. 1981. Hypnotic and antiepileptic effects of cannabidiol. Journal of Clinical Pharmacology 21: 417–427.CrossRefGoogle Scholar
  7. Clarke, R. C. & M. D. Merlin. 2013. Cannabis: Evolution and ethnobotany. University of California Press, Los Angeles.Google Scholar
  8. ——— & ———. 2015. Rebuttal to: Small, Ernest. 2015. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Botanical Review 81(3): 189–294. Botanical Review: xx–xx.CrossRefGoogle Scholar
  9. Devinsky, O., M. R. Cilio, H. Cross, J. Fernandez-Ruiz, J. French, C. Hill, R. Katz, V. Di Marzo, D. Jutras-Aswad, W. G. Notcutt, J. Martinez-Orgado, P. J. Robson, B. G. Rohrback, E. Thiele, B. Whalley & D. Friedman. 2014. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55: 791–802.CrossRefPubMedGoogle Scholar
  10. Fernández-Ruiz, J., O. Sagredo, M. R. Pazos, C. García, R. Pertwee, R. Mechoulam & J. Martínez-Orgado. 2013. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology 75: 323–333.PubMedCentralCrossRefPubMedGoogle Scholar
  11. Hillig, K. W. 2004. A multivariate analysis of allozyme variation in 93 Cannabis accessions from the VIR germplasm collection. Journal of Industrial Hemp 9(2): 5–22.Google Scholar
  12. Lubell, M. 2012. What a drag, Israeli firm grows “highless” marijuana. Reuters July 3, 2012. http://www.reuters.com/article/2012/07/03/us-israelmarijuana-idUSBRE8620FU20120703 (accessed Oct 16, 2015).
  13. McNeill, J., F. R. Barrie, W. R. Buck, V. Demoulin, W. Greuter, D. L. Hawksworth, P. S. Herendeen, S. Knapp, K. Marhold, J. Prado, W. F. Prud’homme van Reine, G. F. Smith, J. H. Wiersema & N. J. Turland. (eds.). 2012. International code of nomenclature for algae, fungi, and plants (Melbourne Code). Koelz Scientific Books, Koenigstein, Germany (Regnum Vegetabile 154.) http://www.iapt-taxon.org/nomen/main.php?page=title. (Accessed Oct. 16, 2015.)
  14. Nicholson, A. N., C. Turner, B. M. Stone & P. J. Robson. 2004. Effect of Δ9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology 24: 305–313.CrossRefPubMedGoogle Scholar
  15. Pickens, J. T. 1981. Sedative activity of cannabis in relation to its Δ1-trans-tetrahydrocannabinol and cannabidiol content. British Journal of Pharmacology 72: 649–656.PubMedCentralCrossRefPubMedGoogle Scholar
  16. Quattrocchi, U. 2000. CRC World Dictionary of Plant names, common names, scientific names, eponyms, synonyms, and etymology, Vol. 4 vols. CRC Press, Boca Raton.Google Scholar
  17. Russo, E. B. & G. W. Guy. 2006. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Medical Hypotheses 66: 234–246.CrossRefPubMedGoogle Scholar
  18. Sawler, J., J. M. Stout, K. M. Gardner, D. Hudson, J. Vidmar, L. Butler, J. E. Page & S. Myles. 2015. The genetic structure of marijuana and hemp. PLoS ONE 10(8), e0133292. doi:10.1371/journal.pone.0133292.PubMedCentralCrossRefPubMedGoogle Scholar
  19. Small, E. 1996. Confusion of common names for toxic and edible “star anise” (Illicium) species. Economic Botany 50: 337–339.CrossRefGoogle Scholar
  20. ——— 2004. Narcotic plants as sources of medicinals, nutraceuticals, and functional foods. Pp. 11–67. In: F.-F. Hou, H.-S. Lin, M.-H. Chou & T.W. Chang (eds). Proceedings of the international symposium on the development of medicinal plants, 24–25 Aug. 2004, Hualien District Agricultural Research and Extension Station, Hualien. Hualien, Taiwan. http://www.hdares.gov.tw/htmlarea_file/web_articles/hdais/1370/9308_11-68.pdf. (Accessed Oct. 16, 2015.)
  21. ——— 2015. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Botanical Review 81: 189–294.CrossRefGoogle Scholar
  22. ——— & D. Marcus. 2003. Tetrahydrocannabinol levels in hemp (Cannabis sativa) germplasm resources. Economic Botany 57: 545–558.Google Scholar
  23. ——— & S. G. U. Naraine. 2015. Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana). Genetic Resources and Crop Evolution 62: in press. doi: 10.1007/s10722-015-0254-2.
  24. Zuardi, A. W. 2008. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Revista Brasileira de Psiquiatria 30: 271–280.CrossRefPubMedGoogle Scholar

Cannabis Sativa Monograph Pdf File Download

Marijuana (cannabis) is a green, brown or gray mixture of dried, shredded leaves, stems, seeds and flowers of the hemp plant Cannabis sativa. Marijuana is used as a psychoactive (i.e. Mind altering) recreational drug, for certain medical ailments and for religious and spiritual purposes. Cannabis spp. American Herbal Pharmacopoeia. Methods other than those presented in this monograph may be scientifically valid and provide reliable results. However, all methods must be verified as being scientifically valid prior to use for regulatory compliance. Logical characteristics comparable to Cannabis sativa, e.g., Hibiscus.

Cannabis sativa monograph pdf file downloadStability monograph pdf

Medical Cannabis Sativa

  1. Andersson, M. S. & M. C. de Vicente. 2010. Gene flow between crops and their wild relatives. Johns Hopkins University Press, Baltimore.Google Scholar
  2. Benet, S. 1975. Early diffusion and folk uses of hemp. Pp 39–49. In: V. Rubin (ed). Cannabis and culture. Mouton, The Hague.Google Scholar
  3. Bouquet, R. J. 1950. Cannabis. Bulletin on Narcotics 2(4): 14–30.Google Scholar
  4. Brickell, C. D., C. Alexander, J. C. David, W. L. A. Hetterscheid, A. C. Leslie, V. Malecot, X. Jin & J. J. Cubey. 2009. International code of nomenclature for cultivated plants. International Society for Horticultural Science, Leuven. http://www.actahort.org/chronica/pdf/sh_10.pdf (accessed Oct 16, 2015).
  5. Burstein, S. 2015. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry 23: 1377–1385.CrossRefGoogle Scholar
  6. Carlini, E. A. & J. M. Cunha. 1981. Hypnotic and antiepileptic effects of cannabidiol. Journal of Clinical Pharmacology 21: 417–427.CrossRefGoogle Scholar
  7. Clarke, R. C. & M. D. Merlin. 2013. Cannabis: Evolution and ethnobotany. University of California Press, Los Angeles.Google Scholar
  8. ——— & ———. 2015. Rebuttal to: Small, Ernest. 2015. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Botanical Review 81(3): 189–294. Botanical Review: xx–xx.CrossRefGoogle Scholar
  9. Devinsky, O., M. R. Cilio, H. Cross, J. Fernandez-Ruiz, J. French, C. Hill, R. Katz, V. Di Marzo, D. Jutras-Aswad, W. G. Notcutt, J. Martinez-Orgado, P. J. Robson, B. G. Rohrback, E. Thiele, B. Whalley & D. Friedman. 2014. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55: 791–802.CrossRefPubMedGoogle Scholar
  10. Fernández-Ruiz, J., O. Sagredo, M. R. Pazos, C. García, R. Pertwee, R. Mechoulam & J. Martínez-Orgado. 2013. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology 75: 323–333.PubMedCentralCrossRefPubMedGoogle Scholar
  11. Hillig, K. W. 2004. A multivariate analysis of allozyme variation in 93 Cannabis accessions from the VIR germplasm collection. Journal of Industrial Hemp 9(2): 5–22.Google Scholar
  12. Lubell, M. 2012. What a drag, Israeli firm grows “highless” marijuana. Reuters July 3, 2012. http://www.reuters.com/article/2012/07/03/us-israelmarijuana-idUSBRE8620FU20120703 (accessed Oct 16, 2015).
  13. McNeill, J., F. R. Barrie, W. R. Buck, V. Demoulin, W. Greuter, D. L. Hawksworth, P. S. Herendeen, S. Knapp, K. Marhold, J. Prado, W. F. Prud’homme van Reine, G. F. Smith, J. H. Wiersema & N. J. Turland. (eds.). 2012. International code of nomenclature for algae, fungi, and plants (Melbourne Code). Koelz Scientific Books, Koenigstein, Germany (Regnum Vegetabile 154.) http://www.iapt-taxon.org/nomen/main.php?page=title. (Accessed Oct. 16, 2015.)
  14. Nicholson, A. N., C. Turner, B. M. Stone & P. J. Robson. 2004. Effect of Δ9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology 24: 305–313.CrossRefPubMedGoogle Scholar
  15. Pickens, J. T. 1981. Sedative activity of cannabis in relation to its Δ1-trans-tetrahydrocannabinol and cannabidiol content. British Journal of Pharmacology 72: 649–656.PubMedCentralCrossRefPubMedGoogle Scholar
  16. Quattrocchi, U. 2000. CRC World Dictionary of Plant names, common names, scientific names, eponyms, synonyms, and etymology, Vol. 4 vols. CRC Press, Boca Raton.Google Scholar
  17. Russo, E. B. & G. W. Guy. 2006. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Medical Hypotheses 66: 234–246.CrossRefPubMedGoogle Scholar
  18. Sawler, J., J. M. Stout, K. M. Gardner, D. Hudson, J. Vidmar, L. Butler, J. E. Page & S. Myles. 2015. The genetic structure of marijuana and hemp. PLoS ONE 10(8), e0133292. doi:10.1371/journal.pone.0133292.PubMedCentralCrossRefPubMedGoogle Scholar
  19. Small, E. 1996. Confusion of common names for toxic and edible “star anise” (Illicium) species. Economic Botany 50: 337–339.CrossRefGoogle Scholar
  20. ——— 2004. Narcotic plants as sources of medicinals, nutraceuticals, and functional foods. Pp. 11–67. In: F.-F. Hou, H.-S. Lin, M.-H. Chou & T.W. Chang (eds). Proceedings of the international symposium on the development of medicinal plants, 24–25 Aug. 2004, Hualien District Agricultural Research and Extension Station, Hualien. Hualien, Taiwan. http://www.hdares.gov.tw/htmlarea_file/web_articles/hdais/1370/9308_11-68.pdf. (Accessed Oct. 16, 2015.)
  21. ——— 2015. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Botanical Review 81: 189–294.CrossRefGoogle Scholar
  22. ——— & D. Marcus. 2003. Tetrahydrocannabinol levels in hemp (Cannabis sativa) germplasm resources. Economic Botany 57: 545–558.Google Scholar
  23. ——— & S. G. U. Naraine. 2015. Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana). Genetic Resources and Crop Evolution 62: in press. doi: 10.1007/s10722-015-0254-2.
  24. Zuardi, A. W. 2008. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Revista Brasileira de Psiquiatria 30: 271–280.CrossRefPubMedGoogle Scholar